Larry Summers resigns from OpenAI board after release of emails with Epstein

Larry Summers resigns from OpenAI board after release of emails with Epstein

Larry Summers, president emeritus and professor at Harvard University, at the World Economic Forum (WEF) in Davos, Switzerland, on Tuesday, Jan. 21, 2025.  Stefan Wermuth | Bloomberg | Getty Images Former Treasury Secretary Larry Summers said Wednesday that he will resign from the board at OpenAI after the release of emails between him and the notorious sex offender Jeffrey Epstein. Summers had announced…

Read More
Trump appointee Bill Pulte files 2nd criminal referral

Trump appointee Bill Pulte files 2nd criminal referral

Federal Reserve Governor Lisa Cook attends the Federal Reserve Bank of Kansas City’s 2025 Jackson Hole economic symposium, “Labor Markets in Transition: Demographics, Productivity, and Macroeconomic Policy” in Jackson Hole, Wyoming, U.S., August 23, 2025. Jim Urquhart | Reuters Federal Housing Finance Agency Director Bill Pulte on Thursday night said that he had filed a…

Read More
How the ousting of Russia’s ally Maduro benefits Moscow

How the ousting of Russia’s ally Maduro benefits Moscow

Venezuela’s President Nicolas Maduro shakes hands with his Russia counterpart Vladimir Putin during a meeting at the Moscow Kremlin. Mikhail Metzel | TASS |Getty Images Russia’s reaction to the ousting of Venezuelan President Nicolas Maduro has been cautious, with Moscow weighing up the potential geopolitical benefits and opportunities of the U.S.’ unilateral action against the…

Read More
Why Wall Street and Jim Cramer think Danaher stock is ‘ready to go for a romp’

Why Wall Street and Jim Cramer think Danaher stock is ‘ready to go for a romp’

Danaher is finally turning the corner. CNBC’s Jim Cramer sees it. Wall Street does, too. The life sciences stock is “ready to go for a romp” after years of “nightmare” performance, Cramer said during Friday’s December Monthly Meeting for Investing Club members. Danaher — which makes tools and technologies used by pharmaceutical, biotech, and medical…

Read More